BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25124465)

  • 1. Letter to the editor.
    Abarzúa A; Sandoval M; González S; Giesen L
    Int J Dermatol; 2014 Sep; 53(9):1180-1. PubMed ID: 25124465
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleromyxedema: successful treatment with thalidomide in two patients.
    Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
    Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleromyxedema without paraproteinemia.
    Abarzúa AA; Giesen LF; Sandoval MO; González SB
    Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleromyxedema--thalidomide therapy.
    Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of scleromyxedema with oral thalidomide.
    Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
    Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Response to thalidomide in scleromyxedema].
    Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
    Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleromyxedema, a positive effect with thalidomide.
    Jacob SE; Fien S; Kerdel FA
    Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
    Efthimiou P; Blanco M
    Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
    do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
    Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of scleromyxedema using thalidomide.
    Thyssen JP; Zachariae C; Menné T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1396-7. PubMed ID: 17062103
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual presentation of scleromyxedema as inflammatory myopathy.
    Vysakha KV; Poyuran R; Nair SS; Nair M
    Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleromyxedema with myopathy was successfully treated by thalidomide.
    Wu MY; Hong JB; Yang CC; Hu SL; Liao YH
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):189-90. PubMed ID: 18435730
    [No Abstract]   [Full Text] [Related]  

  • 13. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
    Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
    Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleromyxoedema: the importance of physical examination.
    Pipa S; Sá J; Mondragão A; Marinho A
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317211
    [No Abstract]   [Full Text] [Related]  

  • 15. Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.
    Yeung CK; Loong F; Kwong YL
    Br J Haematol; 2012 May; 157(4):411. PubMed ID: 22429092
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
    Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
    Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 18. Scleromyxedema.
    Hummers LK
    Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
    Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
    J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
    [No Abstract]   [Full Text] [Related]  

  • 20. Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.
    Peter LM; Ammoury A; Chiavassa-Gandois H; Lamant L; Paul CF
    Clin Exp Dermatol; 2008 Aug; 33(5):606-10. PubMed ID: 18477005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.